ISBN 1-85765-766-7

Table of Contents

Executive Summary

Back to Community Service, Health, Defence and Social Services Index

Normally £311 - Our Price £287.67 - SAVE £23.33

TABLE OF CONTENTS

Executive Summary

Market Definition

INTRODUCTION

MARKET POSITION

MARKET SECTORS

MARKET TRENDS

Table 1: Total Number of Admissions to NHS Hospitals for Plastic Surgery, 1994-1997

Table 2: Breakdown of Plastic Surgery Within the NHS ( percent of total), 1996

Table 3: Number of Cosmetic Surgical Operations in the UK by Market Sector, 1996 and 1997

Market Size

THE TOTAL MARKET

BY MARKET SECTOR

AVERAGE FEES

Table 4: The Total UK Cosmetic Surgery Market by Estimated Revenue (£m), 1993-1997

Table 5: Profile of Estimated Cosmetic Surgery Revenues by Market Sector (£000), 1997

Table 6: Average Fees for Cosmetic Surgery Procedures (£), 1997

Industry Background

RECENT HISTORY

INDUSTRY CONCENTRATION

TRAINING AND QUALIFICATIONS

EMPLOYMENT

DISTRIBUTION

TRADE ASSOCIATIONS

LEGISLATION

Competitor Analysis

THE MARKETPLACE

MARKET LEADERS

ADVERTISING AND PROMOTION

Table 7: Estimated Number of Cosmetic Surgery Operations Performed by Major Clinics and Hospitals in the UK (number of operations and percent), 1996

Table 8: Estimated Number of Plastic Surgical Operations Performed in NHS Hospitals, 1992/1993-1995/1996

Table 9: Prices for Selected cosmetic Surgery Procedures from Cosmetic Surgery Direct (£), 1997

Table 10: Prices for Selected Cosmetic Surgery Procedures from Euromedica (£), 1997

Table 11: Prices for Selected Cosmetic Surgery Procedures at Guy's Nuffield House (£), 1997

Table 12: Prices for Selected Procedures at the Harley Street Clinic (£), 1997

Table 13: Prices for Selected Cosmetic Surgery Procedures at The Pountney Clinic (£), 1997

Table 14: Prices for Selected Cosmetic Surgery Procedures at The West Hampstead Clinic (£), 1997

Table 15: Main Media Advertising Expenditure for Cosmetic Surgery Clinics (£000), 1996 and 1997

Strengths, Weaknesses, Opportunities and Threats (SWOT)

STRENGTHS

WEAKNESSES

OPPORTUNITIES

THREATS

Buying Behaviour

DEMAND FOR COSMETIC SURGERY

CONSUMER RESEARCH

TYPES OF COSMETIC SURGERY

Table 16: 'I Have Had Cosmetic Surgery in the Last Couple of Years' by Sex, Age, Social Class and Region ( percent agreeing), 1997

Table 17: Consumers Who Would Consider Ear Reshaping by Sex, Age, Social Class and Region ( percent agreeing), 1997

Table 18: Consumers Who Would Consider a 'Nose Job' by Sex, Age, Social Class and Region ( percent agreeing), 1997

Table 19: Consumers Who Would Consider a Face-Lift by Sex, Age, Social Class and Region ( percent agreeing), 1997

Table 20: Consumers Who Would Consider a Face Reshaping by Sex, Age, Social Class and Region ( percent agreeing), 1997

Table 21: Consumers Who Would Consider Eye Bag Removal by Sex, Age, Social Class and Region ( percent agreeing), 1997

Table 22: Consumers Who Would Consider Wrinkles Removal by Sex, Age, Social Class and Region ( percent agreeing), 1997

Table 23: Consumers Who Would Consider Breast Reduction, Enlargement or Improvement by Sex, Age, Social Class and Region ( percent agreeing), 1997

Table 24: Consumers Who Would Consider Body Tucks by Sex, Age, Social Class and Region ( percent agreeing), 1997

Table 25: Consumers Who Would Consider Fat Removal by Sex, Age, Social Class and Region ( percent agreeing), 1997

Table 26: Consumers Who Would Consider Tattoo Removal by Sex, Age, Social Class and Region ( percent agreeing), 1997

Outside Suppliers to the Industry

COLLAGEN

SKIN

BREAST IMPLANTS

Current Issues

INTRODUCTION

COMPLICATIONS OF COSMETIC SURGERY

MEDICAL ADVANCES AND DEVELOPMENTS

CORPORATE ACTIVITY

Table 27: Possible Complications of Cosmetic Surgery, 1997

Forecasts

FORECASTS 1997 TO 2002

Table 28: Forecast Total UK Market for Cosmetic Surgery (£m), 1997-2002

Glossary

Further Sources

ASSOCIATIONS

PERIODICALS

DIRECTORIES

GENERAL SOURCES

HBI UK INFORMATION SOURCES

GOVERNMENT PUBLICATIONS

OTHER SOURCES

Back to Top

EXECUTIVE SUMMARY

Cosmetic surgery is showing an increasingly high profile in the UK. Traditionally, cosmetic surgery has been the preserve of the affluent, older woman and patients were generally discrete about any treatment that they had undergone. Cosmetic surgery, or aesthetic plastic surgery as it is also known, is performed in order to correct perceived defects in appearance or minimise the effects of ageing. It is predominantly carried out in the private sector, but can be obtained on the National Health Service (NHS) on a strictly regulated basis, only if there is an evident psychological or functional need.

It is estimated that the most commonly performed procedures are non-surgical techniques including laser therapy, chemical peeling, dermabrasion and collagen therapy. The most common surgical procedures are those of fat reduction, including liposuction, liposculpture and abdominoplasty, at an estimated 11,159 procedures in 1997.

The market for cosmetic surgery was estimated to be worth £119.5m in 1996, growing by 9.3 percent to £130.6m in 1997. The largest sector in value terms was breast enhancement, with 25.8 percent of the market, followed by fat reduction at 21.5 percent. This indicates the high cost of these operations in comparison to non-surgical techniques.

The market is set to grow rapidly, fuelled by developments in medical technology such as `keyhole' surgery and laser surgery, which are increasing the type and scope of procedures, as well as reducing recovery times significantly. Also, the increasing pool of previous surgery recipients is increasing, giving rise to a further long-term increase in the market, as many procedures have a limited life. The market is predicted to rise steadily reaching £208.3m by the year 2002.

The market is largely unregulated, and as the law stands, it is possible for relatively unqualified people to set themselves up as cosmetic surgeons without formal approval. A private member's bill introduced initially in 1994 did not succeed.

The controversy over breast implants rages on, with many recipients claiming different forms of side effects. The product is currently being tested. A number of surveys would seem to indicate that no connective tissue disease is likely and the publicity and bans in the US and France have not deterred many women. The number of women in the UK currently receiving or seeking treatment seems largely unaffected by the publicity.

Text © 1997 Key Note

Back to Top

Back To REPORTFINDER HOME PAGE

Ariadne - working together with our customers to enhance productivity and increase knowledge

© 1999 www.the-list.co.uk Ariadne

Last updated by Duncan Nottage 5th March 1999